Abstract:Bruton's tyrosine kinase (Btk) is a signaling molecule involved in development and activation of B cells through B-cell receptor (BCR) and Toll-like receptor (TLR) signaling. We have previously shown that transgenic mice that overexpress human Btk under the control of the CD19 promoter (CD19-hBtk) display spontaneous germinal center formation, increased cytokine production, anti-nuclear autoantibodies (ANAs), and systemic autoimsmune disease upon aging. As TLR and BCR signaling are both implicated in autoimmunity, we studied their impact on splenic B cells. Using phosphoflow cytometry, we observed that phosphorylation of ribosomal protein S6, a downstream Akt target, was increased in CD19-hBtk B cells following BCR stimulation or combined BCR/TLR stimulation, when compared with wild-type (WT) B cells. The CD19-hBtk transgene enhanced BCR-induced B cell survival and proliferation, but had an opposite effect following TLR9 or combined BCR/TLR9 stimulation. Although the expression of TLR9 was reduced in CD19-hBtk B cells compared to WT B cells, a synergistic effect of TLR9 and BCR stimulation on the induction of CD25 and CD80 was observed in CD19-hBtk B cells. In splenic follicular (Fol) and marginal zone (MZ) B cells from aging CD19-hBtk mice BCR signaling stimulated <i>in vitro</i> IL-10 production in synergy with TLR4 and particularly TLR9 stimulation, but not with TLR3 and TLR7. The enhanced capacity of CD19-hBtk Fol B cells to produce the pro-inflammatory cytokines IFNγ and IL-6 compared with WT B cells was however not further increased following <i>in vitro</i> BCR or TLR9 stimulation. Finally, we used crosses with mice deficient for the TLR-associated molecule myeloid differentiation primary response 88 (MyD88) to show that TLR signaling was crucial for spontaneous formation of germinal centers, increased IFNγ, and IL-6 production by B cells and anti-nuclear autoantibody induction in CD19-hBtk mice. Taken together, we conclude that high Btk expression does not only increase B cell survival following BCR stimulation, but also renders B cells more sensitive to TLR stimulation, resulting in increased expression of CD80, and IL-10 in activated B cells. Although BCR-TLR interplay is complex, our findings show that both signaling pathways are crucial for the development of pathology in a Btk-dependent model for systemic autoimmune disease.

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension

Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis

B cells in pulmonary arterial hypertension: friend, foe or bystander?

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension

Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

Lymphocyte Involvement in the Pathology of Pulmonary Arterial Hypertension

Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension.

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension

Immune Cells in Pulmonary Arterial Hypertension.

A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension

Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension

Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension

The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension

Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease

Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer

Th2-skewed peripheral T helper cells drives B cells in allergic bronchopulmonary aspergillosis

Th2-skewed Peripheral T-helper Cells Drive B-cells in Allergic Bronchopulmonary Aspergillosis

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

Decreased Expression of B- and T-lymphocyte Attenuator (BTLA) is Associated with Progression of Disease in Idiopathic Pulmonary Fibrosis (IPF) (54.7)

Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile